KVUENYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends January 3
Kenvue Inc.
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 6, 2026
$18.87−0.04 (-0.21%)
Close on Oct 19, 2026
- Market cap
- $36.29B
- P/E (TTM)
- 21.7
- Dividend yield
- 4.37%
Margins
Share of revenue, fiscal years 2020 to 2025
Gross margin
58.1%
Operating margin
16.0%
Net margin
9.7%
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -2.1% | +0.4% | – | – | |
| Gross profit | -1.9% | +2.0% | – | – | |
| Operating income | +31.1% | -3.4% | – | – | |
| Net income | +42.7% | -10.7% | – | – | |
| EPS, diluted | +40.7% | -14.1% | – | – | |
| Free cash flow | +29.0% | -7.1% | – | – | |
| Dividend per share | +1.9% | – | – | – |
Returns and balance sheet
6 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2020 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | 14.4% | |
| Return on assets | – | – | 5.6% | |
| Current ratio | – | – | 0.96 | |
| Interest coverage | – | – | 5.6× | |
| Inventory turnover | – | – | 3.9× | |
| Capex to revenue | – | – | 3.1% | |
| Diluted shares | – | – | 1.92B |
Where the cash went
Fiscal 2021 to 2025, five years combined
Kenvue generated $9.99B from operations and spent $6.39B on capital expenditure, dividends and share buybacks. 32% of that went back into the business.
Generated
$9.99B
Used
$6.39B
Capital expenditure$2.05B32%Dividends$3.90B61%Share buybacks$439.00M7%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin9.7%
×Asset turnover0.57×
×Equity multiplier2.58×
=Return on equity, FY202514.4%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 9.7% | 0.57× | 2.58× | 14.4% |
| FY2024 | 6.7% | 0.58× | 2.56× | 9.9% |
| FY2023 | 10.8% | 0.56× | 1.77× | 10.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
6of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$1.47B
- Cash generatingOperating cash flow above zero$2.20B
- Return on assets improvedROA up on the prior year3.7% → 5.7%
- Earnings backed by cashOperating cash flow above net income$2.20B vs $1.47B
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose0.96 → 0.96
- No dilutionShare count did not rise1.92B → 1.92B
- Gross margin improvedGross margin up on the prior year57.97% → 58.13%
- More efficientAsset turnover rose0.55 → 0.59